Assessment of Long-Term Infliximab for Psoriasis (P05319)
Clinical trial NCT00779675 · COMPLETED
Trial details
- NCT number
- NCT00779675
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-10-01
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.